RITE AID CORP (RAD) [Rocket]

In millions, except per share items	Feb-26-22	Feb-27-21	Feb-29-20	Mar-02-19	Mar-03-18	Mar-04-17	Feb-27-16	Feb-28-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Retail Pharmacy	17,494.8	16,365.3	15,616.2	15,757.2	15,832.6	16,766.6	16,820.4	26,528.4
Pharmacy Services	7,323.1	7,970.1	6,559.6	6,093.7	5,896.7	6,393.9	4,103.5
Total revenues	24,568.3	24,043.2	21,928.4	21,639.6	21,529.0	22,927.5	20,770.2	26,528.4
Revenue growth [+]	2.2%	9.6%	1.3%	0.5%	-6.1%	10.4%	-21.7%	3.9%
Retail Pharmacy	6.9%	4.8%	-0.9%	-0.5%	-5.6%	-0.3%	-36.6%	3.9%
Pharmacy Services	-8.1%	21.5%	7.6%	3.3%	-7.8%	55.8%
Unit growth	34900.0%	-99.7%	-0.3%	-3.2%	-43.8%	-0.5%	-0.2%	-0.4%
Cost of goods sold	19,461.8	19,338.9	17,201.6	16,963.2	16,748.9	17,862.8	15,778.3	18,951.6
Gross profit	5,106.5	4,704.3	4,726.8	4,676.4	4,780.1	5,064.7	4,992.0	7,576.7
Gross margin	20.8%	19.6%	21.6%	21.6%	22.2%	22.1%	24.0%	28.6%
Selling, general and administrative	5,033.9	4,657.2	4,587.3	4,592.4	4,651.3	4,777.0	4,581.2	6,695.6
Other operating expenses	17.3	-97.7	-107.2	-41.6	-350.9	-6.6	65.8	-3.8
Adjusted EBITDA	364.0	485.0	590.9	495.6	891.6	725.2	744.1	1,324.9
Adjusted EBITDA margin	1.5%	2.0%	2.7%	2.3%	4.1%	3.2%	3.6%	5.0%
Stock-based compensation	13.1	13.0	16.1	12.1	25.8	23.5	37.9	23.4
EBITDA [+]	351.0	472.0	574.9	483.5	865.8	701.7	706.1	1,301.5
EBITDA growth	-25.6%	-17.9%	18.9%	-44.2%	23.4%	-0.6%	-45.7%	10.1%
EBITDA margin	1.4%	2.0%	2.6%	2.2%	4.0%	3.1%	3.4%	4.9%
Depreciation	217.6	238.1	224.3	232.2	238.3	241.8	229.8	298.5
EBITA	133.3	233.9	350.5	251.2	627.5	459.9	476.4	1,003.0
EBITA margin	0.5%	1.0%	1.6%	1.2%	2.9%	2.0%	2.3%	3.8%
Amortization of intangibles	78.0	89.0	103.9	125.6	147.7	165.6	131.4	118.1
EBIT [+]	55.3	144.8	246.6	125.6	479.7	294.4	345.0	884.9
EBIT growth	-61.8%	-41.3%	96.3%	-73.8%	63.0%	-14.7%	-61.0%	13.7%
EBIT margin	0.2%	0.6%	1.1%	0.6%	2.2%	1.3%	1.7%	3.3%
Non-recurring items [+]	409.2	58.4	42.8	487.9	320.5	45.8	40.5	41.9
Asset impairment	409.2	58.4	42.8	483.2	320.5	45.8	40.5	41.9
Interest expense	191.6	201.4	229.7	227.7	202.8	200.1	186.1	397.6
Interest expense	191.6	201.4	229.7	227.7	202.8	200.1	186.1	397.6
Other income (expense), net [+]	3.2	-5.3	-55.7	0.6			33.2	-18.5
Gain (loss) on sale of assets	5.5	-69.3	4.2	-38.0	-25.9	-6.6	-0.6	-3.8
Gain (loss) on debt retirement	-3.2	5.3	55.7	-0.6			-33.2	18.5
Pre-tax income	-542.3	-120.2	-81.6	-589.5	-43.5	48.5	151.6	426.8
Income taxes	-3.8	-20.2	387.6	77.5	306.0	44.4	49.5	-1,682.4
Tax rate	0.7%	16.8%				91.6%	32.7%
Earnings from continuing ops	-538.5	-100.1	-469.2	-911.7	-1,642.5	4.1	38.7	2,114.6
Earnings from discontinued ops		9.2	17.0	244.7	1,293.0	0.0	63.4
Net income	-538.5	-90.9	-452.2	-667.0	-349.5	4.1	102.1	2,114.6
Net margin	-2.2%	-0.4%	-2.1%	-3.1%	-1.6%	0.0%	0.5%	8.0%

Basic EPS [+]	($9.96)	($1.87)	($8.82)	($17.25)	($31.30)	$0.08	$0.04	$2.18
Growth	434.1%	-78.8%	-48.9%	-44.9%	-39895.4%	108.1%	-98.3%	809.2%
Diluted EPS [+]	($9.96)	($1.87)	($8.82)	($17.25)	($31.30)	$0.08	$0.04	$2.08
Growth	434.1%	-78.8%	-48.9%	-44.9%	-40520.3%	108.5%	-98.2%	820.9%

Shares outstanding (basic) [+]	54.1	53.7	53.2	52.9	52.5	52.2	1,024.4	971.1
Growth	0.7%	0.8%	0.7%	0.7%	0.5%	-94.9%	5.5%	5.3%
Shares outstanding (diluted) [+]	54.1	53.7	53.2	52.9	52.5	53.0	1,042.4	1,017.9
Growth	0.7%	0.8%	0.7%	0.7%	-1.1%	-94.9%	2.4%	4.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.